Kobayashi T, Honke K, Kamio K, Sakakibara N, Gasa S, Miyao N, Tsukamoto T, Ishizuka I, Miyazaki T, Makita A
Biochemistry Laboratory, Hokkaido University School of Medicine, Sapporo, Japan.
Br J Cancer. 1993 Jan;67(1):76-80. doi: 10.1038/bjc.1993.12.
A cell line (SMKT-R3) established from human renal cell carcinoma was characterized for the presence of sulfolipids and glycolipid sulfotransferases. Sulfolipids were found to constitute a large part of the acidic glycolipid fraction in SMKT-R3 cells. These findings were confirmed by metabolic labelling with 35S-sulfate. These sulfolipids were expressed at the surface of SMKT-R3 cells as ascertained by cytofluorometry using a monoclonal antibody directed to sulfolipids. Furthermore, markedly high activity levels of glycolipid sulfotransferases were observed in SMKT-R3 cells compared with other cell lines. These results suggest that the increased synthesis of sulfolipids in renal cell carcinoma tissue (Sakakibara et al., 1989. Cancer Res., 49, 335-339) is due to the elevation of the sulfotransferase activities of renal carcinoma cells themselves.
对一株源自人肾细胞癌的细胞系(SMKT-R3)进行了硫脂和糖脂磺基转移酶的检测。结果发现,硫脂在SMKT-R3细胞的酸性糖脂组分中占很大一部分。用35S-硫酸盐进行代谢标记证实了这些发现。通过使用针对硫脂的单克隆抗体进行细胞荧光测定确定,这些硫脂在SMKT-R3细胞表面表达。此外,与其他细胞系相比,在SMKT-R3细胞中观察到糖脂磺基转移酶的活性水平明显较高。这些结果表明,肾细胞癌组织中硫脂合成增加(Sakakibara等人,1989年。癌症研究,49,335-339)是由于肾癌细胞自身磺基转移酶活性的升高。